Skip to content
SPAC Feed

Curated SPACs News

site-advertisement
  • News
  • Opinions
  • Events
  • Videos
  • Resources
  • Contact Us
1 min to read
  • News
Posted on April 5, 2023

S-4 – Adaptimmune Therapeutics PLC (0001621227) (Filer)

Filed: 2023-04-05 AccNo: 0001104659-23-042202 Size: 5 MB
Source: S-4 – Adaptimmune Therapeutics PLC (0001621227) (Filer)

  • share 
  • tweet 
  • share 
Tags: SEC

Post navigation

S-4 – Corebridge Financial, Inc. (0001889539) (Filer)
S-1 – Cardio Diagnostics Holdings, Inc. (0001870144) (Filer)

Trending Stories

  • 26 Capital Acquisition Corp. Announces Liquidation – PR Newswire
    26 Capital Acquisition Corp. Announces Liquidation  PR Newswire Source: 26 Capital Acquisition Corp. Announces Liquidation - PR Newswire
  • Athena Consumer Acquisition Corp. Announces Extension of … – WDRB
    Athena Consumer Acquisition Corp. Announces Extension of ...  WDRB Source: Athena Consumer Acquisition Corp. Announces Extension of ... - WDRB
  • Debt restructuring "will do little to fix Cazoo's rickety engine" – AM
    Debt restructuring "will do little to fix Cazoo's rickety engine"  AM Source: Debt restructuring "will do little to fix Cazoo's rickety...
  • Dash Acquisitions Inc. Takes Position in Aon plc (NYSE:AON) – MarketBeat
    Dash Acquisitions Inc. Takes Position in Aon plc (NYSE:AON)  MarketBeat Source: Dash Acquisitions Inc. Takes Position in Aon plc (NYSE:AON) -...
  • Athena Consumer Acquisition Corp. Announces Extension of … – Marketscreener.com
    Athena Consumer Acquisition Corp. Announces Extension of ...  Marketscreener.com Source: Athena Consumer Acquisition Corp. Announces Extension of ... - Marketscreener.com

SPACs Twitter Feed

Twitter feed is not available at the moment.
  • 1
    • News

    Wilson, Goodwin on Cheche Group's de-SPAC merger, achieving ... - Legal Business Online

  • 2
    • News

    Tailwinds & Turbulence

  • 3
    • News

    Conduit's $1.2bn Nasdaq listing deals another blow to London - The Times


SPAC Feed | Subscribe to Newsletter
  • About Us
  • Contact Us
  • Subscribe
Copyright © 2023 SPAC Feed. All Rights Reserved.